| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/AJMG.B.32080 |
| P698 | PubMed publication ID | 22815225 |
| P50 | author | Yolande A L Pijnenburg | Q97517231 |
| P2093 | author name string | John C van Swieten | |
| Mariet W Elting | |||
| Petra E Cohn-Hokke | |||
| P2860 | cites work | Motor neuron dysfunction in frontotemporal dementia. | Q38486371 |
| The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene | Q38493216 | ||
| Role of Genes and Environments for Explaining Alzheimer Disease | Q22253029 | ||
| Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia | Q24309521 | ||
| Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease | Q24316501 | ||
| Classification of primary progressive aphasia and its variants | Q24594803 | ||
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia | Q24600027 | ||
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 | ||
| Exome sequencing reveals VCP mutations as a cause of familial ALS | Q24631513 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD | Q24634583 | ||
| The prevalence and causes of dementia in people under the age of 65 years | Q24671745 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid | Q28207898 | ||
| Mutations of the prion protein gene phenotypic spectrum | Q28214069 | ||
| Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease | Q28241772 | ||
| Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 | Q28253639 | ||
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
| APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy | Q28259007 | ||
| Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
| Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene | Q28280248 | ||
| Comparison of family histories in FTLD subtypes and related tauopathies | Q28286447 | ||
| APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy | Q28288090 | ||
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease | Q28943325 | ||
| Alzheimer's disease: the amyloid cascade hypothesis | Q29547160 | ||
| Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. | Q51973117 | ||
| Prevalence and patterns of cognitive impairment in sporadic ALS. | Q51989393 | ||
| Risk of dementia among white and African American relatives of patients with Alzheimer disease. | Q53246105 | ||
| Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. | Q53251607 | ||
| Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease. | Q53280948 | ||
| The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease. | Q53283796 | ||
| Dementia, delusions and seizures: storage disease or genetic AD? | Q53288736 | ||
| Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients. | Q53323583 | ||
| DLB and PDD: a role for mutations in dementia and Parkinson disease genes? | Q53324149 | ||
| Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. | Q53338828 | ||
| Early onset familial Alzheimer's disease: Mutation frequency in 31 families. | Q53356699 | ||
| Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline. | Q53372684 | ||
| Estimation of the Genetic Contribution of Presenilin-1 and -2 Mutations in a Population-Based Study of Presenile Alzheimer Disease | Q57419118 | ||
| Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS | Q57970487 | ||
| The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation | Q38939145 | ||
| Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129. | Q39238744 | ||
| The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. | Q39657178 | ||
| Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. | Q40051471 | ||
| Distinct genetic forms of frontotemporal dementia. | Q40059334 | ||
| CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro | Q40063451 | ||
| Emotional responses to APO E genotype disclosure for Alzheimer disease | Q40413758 | ||
| Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. | Q40459078 | ||
| Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations | Q40689416 | ||
| Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His | Q42631618 | ||
| Progranulin plasma levels in the diagnosis of frontotemporal dementia | Q42721059 | ||
| De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia. | Q42735816 | ||
| Prospective 10-year surveillance of human prion diseases in Japan. | Q42882583 | ||
| Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update | Q43073474 | ||
| Genetic contribution of FUS to frontotemporal lobar degeneration | Q43177598 | ||
| High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types | Q43222788 | ||
| Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. | Q43298473 | ||
| Prevalence and causes of early-onset dementia in Japan: a population-based study | Q43462944 | ||
| Presenilin-1-associated abnormalities in regional cerebral perfusion | Q43636981 | ||
| Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy | Q43642578 | ||
| Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia. | Q43935848 | ||
| Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease | Q43994098 | ||
| Familial frontotemporal dementia associated with a novel presenilin-1 mutation | Q44020083 | ||
| 2011 Alzheimer's disease facts and figures | Q44040789 | ||
| Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. | Q44640812 | ||
| The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy | Q44922719 | ||
| Frequency and causes of early-onset dementia in a tertiary referral center in Athens | Q45150364 | ||
| Pick bodies in a family with presenilin-1 Alzheimer's disease | Q45204462 | ||
| Incidence of early-onset dementias in Cambridgeshire, United Kingdom. | Q45291406 | ||
| TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. | Q45927072 | ||
| Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. | Q46745726 | ||
| Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene | Q46954818 | ||
| A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques | Q47661255 | ||
| Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease | Q47679308 | ||
| Familial aggregation in frontotemporal dementia | Q47951956 | ||
| Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu) | Q48160810 | ||
| Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation | Q48237916 | ||
| Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study | Q48247819 | ||
| Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia | Q48250357 | ||
| Early-versus late-onset Alzheimer's disease: more than age alone | Q48350571 | ||
| The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene | Q48384348 | ||
| Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study | Q48387371 | ||
| Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease | Q48437807 | ||
| Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation | Q48444836 | ||
| Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease | Q48484561 | ||
| A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study | Q48791547 | ||
| Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations | Q48946579 | ||
| A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient | Q49046743 | ||
| Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. | Q50747108 | ||
| Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. | Q51967426 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease | Q29614881 | ||
| Amyloid precursor protein trafficking, processing, and function | Q29617429 | ||
| Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein | Q29619232 | ||
| Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. | Q30493972 | ||
| The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration | Q30495415 | ||
| Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration | Q30503638 | ||
| Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. | Q32061209 | ||
| Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland | Q33394006 | ||
| Survival in Alzheimer disease: a multiethnic, population-based study of incident cases | Q33745430 | ||
| Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies | Q33747695 | ||
| Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). | Q33749062 | ||
| Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration | Q33830991 | ||
| Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum | Q33870467 | ||
| FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration | Q33922335 | ||
| Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia | Q33955043 | ||
| Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease | Q33955976 | ||
| The prevalence of frontotemporal dementia | Q33959615 | ||
| Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin | Q33984548 | ||
| Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration | Q33999208 | ||
| Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia | Q34101831 | ||
| Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia | Q34125553 | ||
| Phenotypic correlations in FTDP-17. | Q34133461 | ||
| High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes | Q34146052 | ||
| The diagnosis of young-onset dementia. | Q34165340 | ||
| Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms | Q34279220 | ||
| Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes | Q34624775 | ||
| Hereditary frontotemporal dementia caused by Tau gene mutations. | Q34627056 | ||
| Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop | Q34736093 | ||
| Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies | Q34901990 | ||
| The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice | Q35014661 | ||
| Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype | Q35043994 | ||
| APOE and Alzheimer disease: a major gene with semi-dominant inheritance | Q35181990 | ||
| A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances. | Q35465346 | ||
| Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees | Q35694218 | ||
| Familial aggregation of dementia with Lewy bodies | Q35712599 | ||
| Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 | Q35752001 | ||
| Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations | Q35776901 | ||
| Chromosome 9 ALS and FTD locus is probably derived from a single founder | Q35853974 | ||
| Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors | Q35889850 | ||
| Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease | Q36226675 | ||
| Repeat expansion in C9ORF72 in Alzheimer's disease | Q36441618 | ||
| Mutation in the tau gene in familial multiple system tauopathy with presenile dementia | Q36507684 | ||
| Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity. | Q36573186 | ||
| Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations | Q36583604 | ||
| The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families | Q36680315 | ||
| Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience | Q36790121 | ||
| Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene | Q36962892 | ||
| Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members | Q37148011 | ||
| Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN | Q37180625 | ||
| Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease | Q37181302 | ||
| Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease | Q37219754 | ||
| A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing | Q37253462 | ||
| CSF biomarkers in frontotemporal lobar degeneration with known pathology | Q37253492 | ||
| Clinical genetics and genetic counseling in Alzheimer disease | Q37299137 | ||
| Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis | Q37336139 | ||
| Disclosure of APOE genotype for risk of Alzheimer's disease | Q37423417 | ||
| The heritability and genetics of frontotemporal lobar degeneration. | Q37425094 | ||
| Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic review. | Q37513928 | ||
| The molecular basis of frontotemporal dementia | Q37564674 | ||
| EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias | Q37713969 | ||
| Amyloid-independent mechanisms in Alzheimer's disease pathogenesis | Q37808579 | ||
| Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management | Q37819287 | ||
| Cerebral amyloid angiopathy: a systematic review | Q37868950 | ||
| Genetic counseling for frontotemporal dementias | Q37879976 | ||
| Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia. | Q37929017 | ||
| Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations | Q38392876 | ||
| Frontotemporal lobar degeneration: demographic characteristics of 353 patients | Q38414577 | ||
| Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging. | Q38484728 | ||
| P433 | issue | 6 | |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 628-643 | |
| P577 | publication date | 2012-07-19 | |
| P1433 | published in | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | Q15762380 |
| P1476 | title | Genetics of dementia: update and guidelines for the clinician | |
| P478 | volume | 159B |
| Q35006348 | A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function |
| Q27025567 | An algorithmic approach to structural imaging in dementia |
| Q39413097 | Biomarkers in Neurodegenerative Diseases |
| Q37251674 | C9ORF72 repeat expansions in cases with previously identified pathogenic mutations |
| Q33737786 | Clinical genetics of Alzheimer's disease |
| Q37606162 | Early-onset dementias: diagnostic and etiological considerations |
| Q30736208 | Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology |
| Q41971441 | Frontotemporal dementia parkinsonism: Clinical findings in a large Iranian family |
| Q28535250 | GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals |
| Q90182692 | Genetic predictors of survival in behavioral variant frontotemporal degeneration |
| Q56069696 | Genetics of dementia |
| Q36332872 | Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APP |
| Q55072013 | Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohort. |
| Q102059040 | Mutational analysis in familial Alzheimer's disease of Han Chinese in Taiwan with a predominant mutation PSEN1 p.Met146Ile |
| Q38105048 | Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions? |
| Q38115191 | Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum |
| Q47237309 | Neuropathology of frontotemporal lobar degeneration: a review |
| Q39354046 | Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations. |
| Q33626351 | The genetics of dementia |
| Q35008908 | The neurogenetics of atypical parkinsonian disorders |
Search more.